Literature DB >> 20615715

Synthesis and characterization of a triazine dendrimer that sequesters iron(III) using 12 desferrioxamine B groups.

Jongdoo Lim1, Vincent J Venditto, Eric E Simanek.   

Abstract

The synthesis of a third generation triazine dendrimer, 1, containing multiple, iron-sequestering desferrioxamine B (DFO) groups is described. Benzoylation of the hydroxamic acid groups of DFO and formation of a reactive dichlorotriazine provide the intermediate for reaction with the second generation dendrimer displaying twelve amines. This strategy further generalizes the 'functional monomer' approach to generate biologically active triazine dendrimers. Dendrimer 1 is prepared in seven steps in 35% overall yield and displays 12 DFO groups making it 56% drug by weight. Spectrophotometric titrations (UV-vis) show that 1 sequesters iron(III) atoms with neither cooperativity nor significant interference from the dendrimer backbone. Evidence from NMR spectroscopy and mass spectrometry reveals a limitation to this functional monomer approach: trace amounts of O-to-N acyl migration from the protected hydroxamic acids to the amine-terminated dendrimer occurs during the coupling step leading to N-benzoylated dendrimers displaying fewer than 12 DFO groups. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20615715      PMCID: PMC3619556          DOI: 10.1016/j.bmc.2010.05.039

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  39 in total

1.  Chemoselective building blocks for dendrimers from relative reactivity data.

Authors:  Mackay B Steffensen; Eric E Simanek
Journal:  Org Lett       Date:  2003-06-26       Impact factor: 6.005

Review 2.  Hereditary hemochromatosis.

Authors:  Massimo Franchini; Dino Veneri
Journal:  Hematology       Date:  2005-04       Impact factor: 2.269

Review 3.  Free-radical mechanisms in tissue injury.

Authors:  T F Slater
Journal:  Biochem J       Date:  1984-08-15       Impact factor: 3.857

Review 4.  Preclinical and clinical development of deferitrin, a novel, orally available iron chelator.

Authors:  Joanne M Donovan; Melissa Plone; Rafif Dagher; Mark Bree; Judith Marquis
Journal:  Ann N Y Acad Sci       Date:  2005       Impact factor: 5.691

Review 5.  Iron transport.

Authors:  M Wessling-Resnick
Journal:  Annu Rev Nutr       Date:  2000       Impact factor: 11.848

Review 6.  In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug delivery.

Authors:  Michael F Neerman; Wen Zhang; Alan R Parrish; Eric E Simanek
Journal:  Int J Pharm       Date:  2004-08-20       Impact factor: 5.875

7.  Intercepting the synthesis of triazine dendrimers with nucleophilic pharmacophores: a general strategy toward drug delivery vehicles.

Authors:  Vincent J Venditto; Kimberly Allred; Clinton D Allred; Eric E Simanek
Journal:  Chem Commun (Camb)       Date:  2009-08-11       Impact factor: 6.222

8.  Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers.

Authors:  P E Hallaway; J W Eaton; S S Panter; B E Hedlund
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

9.  A divergent route towards single-chemical entity triazine dendrimers with opportunities for structural diversity.

Authors:  Hannah Crampton; Emily Hollink; Lisa M Perez; Eric E Simanek
Journal:  New J Chem       Date:  2007-07-01       Impact factor: 3.591

10.  Acute iron poisoning. Rescue with macromolecular chelators.

Authors:  J R Mahoney; P E Hallaway; B E Hedlund; J W Eaton
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

View more
  1 in total

Review 1.  Polymeric drugs: Advances in the development of pharmacologically active polymers.

Authors:  Jing Li; Fei Yu; Yi Chen; David Oupický
Journal:  J Control Release       Date:  2015-09-26       Impact factor: 9.776

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.